Ascendis Pharma A/S (Ascendis Pharma A/S) Price-to-Operating-Cash-Flow : (As of Apr. 26, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma A/S Price-to-Operating-Cash-Flow?

As of today (2024-04-26), Ascendis Pharma A/S's share price is $135.92. Ascendis Pharma A/S's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-8.94. Hence, Ascendis Pharma A/S's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Ascendis Pharma A/S's Price-to-Operating-Cash-Flow or its related term are showing as below:

ASND's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.725
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Ascendis Pharma A/S's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $-0.82. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-8.94.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -11.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -22.00% per year.

During the past 13 years, Ascendis Pharma A/S's highest 3-Year average Operating Cash Flow per Share Growth Rate was -11.50% per year. The lowest was -193.20% per year. And the median was -27.75% per year.

Ascendis Pharma A/S Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Ascendis Pharma A/S's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma A/S Price-to-Operating-Cash-Flow Chart

Ascendis Pharma A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Ascendis Pharma A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Ascendis Pharma A/S's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Ascendis Pharma A/S's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Pharma A/S's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma A/S's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma A/S's Price-to-Operating-Cash-Flow falls into.

Ascendis Pharma A/S Price-to-Operating-Cash-Flow Calculation

Ascendis Pharma A/S's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	135.92	/	-8.942
	=

Ascendis Pharma A/S's Share Price of today is $135.92.
Ascendis Pharma A/S's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.94.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Ascendis Pharma A/S Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (NAS:ASND) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

http://www.ascendispharma.com

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.